A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis
Status:
Completed
Trial end date:
2018-02-08
Target enrollment:
Participant gender:
Summary
This study consists of three parts: single oral dose escalation in healthy volunteers (Part
A), and multiple oral dose escalations in healthy volunteers (Part B) and in participants
with chronic plaque psoriasis (Part C)